Clinically Speaking with Dr. Wig: The Pandemic, Obesity + New Therapies

A new FDA drug approval for semaglutide or Wegovy brings the promise of better weight management for patients diagnosed with obesity.
Clinically Speaking video series logo

Due to the pandemic, 61% of adults reported undesired weight changes, with 40% gaining an average of 29 pounds. With 70% of Americans already diagnosed with obesity or considered overweight, that’s hardly welcome news.

Learn more about the dangers of obesity and about a recently approved class of medications that is showing promise for weight loss in obese patients.

Sign up for our newsletter to get updated when new videos are available.


Cross Icon
Cross Icon
Ready to learn more?
We’re always looking upward. But this is just the start. Keep up with the latest news, insights, and offerings from Evernorth.
Cross Icon
Cross Icon